Pharmacology and Metabolism of Anti-Epileptic Drugs
This session reviews Pharmacology and Metabolism of Anti-Epileptic Drugs and its most clinically relevant points for exam preparation and bedside decision-making.
Duration
00:02:47
File size
1.62 MB
Practitioner-Guided Note
For Pharmacology and Metabolism of Anti-Epileptic Drugs, use the highest-yield facts to drive concrete treatment decisions. Pay particular attention to GABA-ergic enhancement (valproate, barbiturates, benzodiazepines, gabapentin), Sodium channel blockade (phenytoin, carbamazepine, lamotrigine), and T-type calcium channel targeting for absence seizures (ethosuximide) when choosing therapy, counseling about risk, planning monitoring, and deciding when closer follow-up or escalation is needed.
Key Takeaways
GABA-ergic enhancement (valproate, barbiturates, benzodiazepines, gabapentin)Sodium channel blockade (phenytoin, carbamazepine, lamotrigine)T-type calcium channel targeting for absence seizures (ethosuximide)Benzodiazepines increase chloride channel opening frequency; barbiturates prolong channel durationCenobamate modulates both sodium channels and GABA